Related Experiment Videos
CXCR1+CD4+ T cells in human allergic disease
James N Francis1, Mikila R Jacobson, Clare M Lloyd
1Upper Respiratory Medicine, National Heart and Lung Institute, Imperial College, Dovehouse Street, London SW3 6LY, United Kingdom.
Journal of Immunology (Baltimore, Md. : 1950)
|December 23, 2003
Summary
Chemokine receptor CXCR1 is highly expressed on T cells in patients with atopic disease, suggesting it is a potential therapeutic target for allergic rhinitis and other atopic conditions.
Area of Science:
- Immunology
- Allergy Research
Background:
- Chemokine receptors are crucial for leukocyte migration in allergic inflammation.
- CD4+ T lymphocytes are key players in the immune response to allergens.
Purpose of the Study:
- To investigate the role of chemokine receptor CXCR1 in atopic disease.
- To determine if CXCR1 expression on CD4+ T cells is altered in patients with allergic rhinitis.
Main Methods:
- Flow cytometry and double immunofluorescence were used to identify CXCR1 expression on CD4+ T cells.
- CXCR1 expression was analyzed in peripheral blood, nasal biopsies, and cells from patients undergoing immunotherapy.
- Functional assays assessed the response of CXCR1+CD4+ T cells to CXC chemokine ligand 8 (CXCL8).
Main Results:
- Increased CXCR1 expression was observed on CD4+ T lymphocytes from patients with atopic disease compared to healthy donors.
- CXCR1 expression decreased significantly in patients successfully treated with specific immunotherapy for allergic rhinitis.
- CXCR1+CD4+ T cells from atopic donors showed an enhanced response to CXCL8, which was upregulated at sites of allergic inflammation.
Conclusions:
- CXCR1 is a potential biomarker for allergic rhinitis.
- Targeting CXCR1 may offer a novel therapeutic strategy for atopic diseases.